Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-75.70	21.06	86.65
Graham Fair Price	1.71	49834.07	48996.08
PEG	2089.31	3.86	-0.18
Price/Book	13.80	1.01	0.89
Price/Cash Flow	111.03	-20.00	9.48
Prices/Earnings	9.81	13.68	12.46
Price/Sales	20.07	0.98	0.81
Price/FCF	111.03	-20.00	9.48
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	350.02	0.07	0.02
Operating Margin	750.19	0.05	< 0.005
ROA	0.72	< 0.005	< 0.005
ROE	0.02	0.02	3.63
ROIC	< 0.005	0.02	163.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.04	-8.88
Dividends QOQ	-1.00	-1.00	-0.17
EBIT QOQ	-1.07	9.05	749.32
EPS QOQ	-0.71	0.04	-94.98
FCF QOQ	1.96	-1.54	-21.67
Revenue QOQ	0.09	-0.05	-42.51
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	43.14	55.92	29.63
Days Sales Outstanding (DSO)	27.57	27.30	-0.97
Inventory Turnover	2.09	1.61	-22.86
Debt/Capitalization	0.39	0.39	2.22
Quick Ratio	0.54	0.44	-17.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	77506.00	77436.80	-0.09
Cash	16931.40	13982.80	-17.41
Capex	-7472.56	-2879.74	61.46
Free Cash Flow	7238.07	-3899.94	-46.12
Revenue	84301.16	79829.44	-5.30
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.04	1.02	-1.33
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	28.27	6.88	-75.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating